| Dr Ashley E Young, MD | |
|
282 Washington St, Hartford, CT 06106-3322 | |
| (860) 545-8950 | |
| (860) 545-8959 |
| Full Name | Dr Ashley E Young |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 11 Years |
| Location | 282 Washington St, Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053758128 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 56716 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians For Women's Health, Llc | 3274430665 | 278 |
News Archive
The UAB Center for Education and Research on Therapeutics has won a $2.2 million federal grant to study the risks and benefits of a class of drugs called ‘biologics' - genetically engineered agents targeting the immune system of patients with rheumatoid arthritis, Crohn's disease, psoriasis and other autoimmune disorders.
The offer of federal stimulus funds is spurring Indiana health care providers to convert to electronic medical records, The (Fort Wayne, Ind.) Journal Gazette reports.
In this Washington Post opinion piece, Raj Kumar, president of Devex and a member of the Council on Foreign Relations, and John Hewko, the general secretary and chief executive of Rotary International, report on the Millennium Challenge Corp. (MCC), a government "corporation" established in 2004 under the George W. Bush administration "on the premise that U.S. foreign assistance would have the greatest impact if offered on a non-political basis to developing countries that adopt sound economic and social policies."
Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a (SNG001), a drug used for multiple sclerosis, helped COVID-19 patients have greater odds of improvement and recovery from SARS-CoV-2 infection.
Integra LifeSciences Holdings Corporation announced that it will officially unveil its new corporate identity at the 2010 Congress of Neurological Surgeons Annual Meeting, October 16-21, San Francisco, California. Integra's new brand identity is designed to communicate the company's mission to limit uncertainty for surgeons, so they can concentrate on providing the best patient care.
› Verified 8 days ago
| Entity Name | Connecticut Children's Specialty Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669448882 PECOS PAC ID: 6002720117 Enrollment ID: O20031113000468 |
News Archive
The UAB Center for Education and Research on Therapeutics has won a $2.2 million federal grant to study the risks and benefits of a class of drugs called ‘biologics' - genetically engineered agents targeting the immune system of patients with rheumatoid arthritis, Crohn's disease, psoriasis and other autoimmune disorders.
The offer of federal stimulus funds is spurring Indiana health care providers to convert to electronic medical records, The (Fort Wayne, Ind.) Journal Gazette reports.
In this Washington Post opinion piece, Raj Kumar, president of Devex and a member of the Council on Foreign Relations, and John Hewko, the general secretary and chief executive of Rotary International, report on the Millennium Challenge Corp. (MCC), a government "corporation" established in 2004 under the George W. Bush administration "on the premise that U.S. foreign assistance would have the greatest impact if offered on a non-political basis to developing countries that adopt sound economic and social policies."
Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a (SNG001), a drug used for multiple sclerosis, helped COVID-19 patients have greater odds of improvement and recovery from SARS-CoV-2 infection.
Integra LifeSciences Holdings Corporation announced that it will officially unveil its new corporate identity at the 2010 Congress of Neurological Surgeons Annual Meeting, October 16-21, San Francisco, California. Integra's new brand identity is designed to communicate the company's mission to limit uncertainty for surgeons, so they can concentrate on providing the best patient care.
› Verified 8 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20031215000455 |
News Archive
The UAB Center for Education and Research on Therapeutics has won a $2.2 million federal grant to study the risks and benefits of a class of drugs called ‘biologics' - genetically engineered agents targeting the immune system of patients with rheumatoid arthritis, Crohn's disease, psoriasis and other autoimmune disorders.
The offer of federal stimulus funds is spurring Indiana health care providers to convert to electronic medical records, The (Fort Wayne, Ind.) Journal Gazette reports.
In this Washington Post opinion piece, Raj Kumar, president of Devex and a member of the Council on Foreign Relations, and John Hewko, the general secretary and chief executive of Rotary International, report on the Millennium Challenge Corp. (MCC), a government "corporation" established in 2004 under the George W. Bush administration "on the premise that U.S. foreign assistance would have the greatest impact if offered on a non-political basis to developing countries that adopt sound economic and social policies."
Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a (SNG001), a drug used for multiple sclerosis, helped COVID-19 patients have greater odds of improvement and recovery from SARS-CoV-2 infection.
Integra LifeSciences Holdings Corporation announced that it will officially unveil its new corporate identity at the 2010 Congress of Neurological Surgeons Annual Meeting, October 16-21, San Francisco, California. Integra's new brand identity is designed to communicate the company's mission to limit uncertainty for surgeons, so they can concentrate on providing the best patient care.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ashley E Young, MD 100 Retreat Ave, Suite 201, Hartford, CT 06106-2528 Ph: (860) 246-8568 | Dr Ashley E Young, MD 282 Washington St, Hartford, CT 06106-3322 Ph: (860) 545-8950 |
News Archive
The UAB Center for Education and Research on Therapeutics has won a $2.2 million federal grant to study the risks and benefits of a class of drugs called ‘biologics' - genetically engineered agents targeting the immune system of patients with rheumatoid arthritis, Crohn's disease, psoriasis and other autoimmune disorders.
The offer of federal stimulus funds is spurring Indiana health care providers to convert to electronic medical records, The (Fort Wayne, Ind.) Journal Gazette reports.
In this Washington Post opinion piece, Raj Kumar, president of Devex and a member of the Council on Foreign Relations, and John Hewko, the general secretary and chief executive of Rotary International, report on the Millennium Challenge Corp. (MCC), a government "corporation" established in 2004 under the George W. Bush administration "on the premise that U.S. foreign assistance would have the greatest impact if offered on a non-political basis to developing countries that adopt sound economic and social policies."
Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a (SNG001), a drug used for multiple sclerosis, helped COVID-19 patients have greater odds of improvement and recovery from SARS-CoV-2 infection.
Integra LifeSciences Holdings Corporation announced that it will officially unveil its new corporate identity at the 2010 Congress of Neurological Surgeons Annual Meeting, October 16-21, San Francisco, California. Integra's new brand identity is designed to communicate the company's mission to limit uncertainty for surgeons, so they can concentrate on providing the best patient care.
› Verified 8 days ago
Ellen Robinson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Retreat Ave, Suite 201, Hartford, CT 06106 Phone: 860-246-8568 Fax: 860-728-5076 | |
Howard Andrew Shaw, MD, MBA Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1000 Asylum Ave, Suite 2110, Hartford, CT 06105 Phone: 860-714-7945 Fax: 860-714-8880 | |
Mark Wolf, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Asylum Ave, Suite 4319, Hartford, CT 06105 Phone: 860-714-4440 Fax: 860-714-8012 | |
Behzad Satvat, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 136 Retreat Ave, Hartford, CT 06106 Phone: 860-547-0306 Fax: 860-525-9782 | |
Felice Colliton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 19 Woodland Street, Suite 31, Hartford, CT 06105 Phone: 860-728-1212 Fax: 860-724-5224 | |
Elena Tunitsky-bitton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 80 Seymour Street, Hartford Hospital Professional Services, Hartford, CT 06102 Phone: 860-545-4338 | |
Dr. Charles J. Ingardia, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 80 Seymour Street, Hartford Hospital Maternal-fetal Medicine, Hartford, CT 06102 Phone: 860-545-2884 |